Xiaolin Yin

1.5k total citations
64 papers, 892 citations indexed

About

Xiaolin Yin is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Xiaolin Yin has authored 64 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 17 papers in Genetics and 14 papers in Molecular Biology. Recurrent topics in Xiaolin Yin's work include Hemoglobinopathies and Related Disorders (16 papers), Acute Myeloid Leukemia Research (8 papers) and Iron Metabolism and Disorders (8 papers). Xiaolin Yin is often cited by papers focused on Hemoglobinopathies and Related Disorders (16 papers), Acute Myeloid Leukemia Research (8 papers) and Iron Metabolism and Disorders (8 papers). Xiaolin Yin collaborates with scholars based in China, United States and Sweden. Xiaolin Yin's co-authors include Xiaorong Yang, Ming Lü, Tongchao Zhang, Jinyu Man, Qiufeng He, Xinhua Zhang, Hui Chen, Chao Shen, Jia Yu and Jun‐Wu Zhang and has published in prestigious journals such as Blood, PLoS ONE and Scientific Reports.

In The Last Decade

Xiaolin Yin

55 papers receiving 885 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaolin Yin China 17 341 193 161 142 116 64 892
Renée M. Ned United States 18 296 0.9× 105 0.5× 297 1.8× 186 1.3× 75 0.6× 31 1.3k
Jan Mužı́k Czechia 19 165 0.5× 97 0.5× 95 0.6× 65 0.5× 93 0.8× 82 860
Masaru Ido Japan 18 277 0.8× 114 0.6× 273 1.7× 112 0.8× 126 1.1× 80 1.1k
Helen C. Owen United Kingdom 18 400 1.2× 267 1.4× 72 0.4× 60 0.4× 87 0.8× 35 1.1k
Ahmad Gharehbaghian Iran 16 302 0.9× 130 0.7× 115 0.7× 166 1.2× 38 0.3× 81 1.0k
Sheng-Fung Lin Taiwan 18 298 0.9× 178 0.9× 135 0.8× 38 0.3× 71 0.6× 53 797
Tae Sung Park South Korea 18 334 1.0× 65 0.3× 368 2.3× 142 1.0× 67 0.6× 90 914
Anna L. Peters Netherlands 15 227 0.7× 56 0.3× 119 0.7× 142 1.0× 119 1.0× 69 1.3k
D. Maroeska W. M. te Loo Netherlands 22 297 0.9× 93 0.5× 209 1.3× 94 0.7× 178 1.5× 73 1.5k
Shano Naseem India 12 181 0.5× 40 0.2× 272 1.7× 179 1.3× 45 0.4× 129 798

Countries citing papers authored by Xiaolin Yin

Since Specialization
Citations

This map shows the geographic impact of Xiaolin Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolin Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolin Yin more than expected).

Fields of papers citing papers by Xiaolin Yin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolin Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolin Yin. The network helps show where Xiaolin Yin may publish in the future.

Co-authorship network of co-authors of Xiaolin Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolin Yin. A scholar is included among the top collaborators of Xiaolin Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolin Yin. Xiaolin Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Peipei, Huangbo Yuan, Zhendong Mei, et al.. (2025). The comprehensive oral microbiome landscape unveils its interplay with poor oral health in esophageal squamous cell carcinoma risk. Cell Reports Medicine. 6(11). 102431–102431.
2.
Yang, Kun, et al.. (2025). Promising activity of Selinexor in the treatment of a patient with refractory NUP98-NSD1+/FLT3-ITD + acute myeloid leukemia. Annals of Hematology. 104(4). 2545–2549. 1 indexed citations
3.
4.
Huang, Jia, et al.. (2024). Humor processing and its relationship with clinical features in patients with first-episode schizophrenia. Schizophrenia Research Cognition. 39. 100337–100337. 1 indexed citations
5.
Yin, Xiaolin, et al.. (2024). Reconstruction for extensive sacrococcygeal defects in complex tumor patients with personalized customized gluteus maximus myocutaneous flaps. Journal of Tissue Viability. 33(4). 883–888. 1 indexed citations
6.
7.
8.
Zhang, Cheng, Xu Tan, Jieping Li, et al.. (2023). Efficacy and toxicity of CLAG combined with pegylated liposomal doxorubicin in the treatment of refractory or relapsed acute myeloid leukemia. Cancer Medicine. 12(11). 12377–12387. 4 indexed citations
9.
Zhou, Yali, Xiaolin Yin, Sheng He, et al.. (2022). THE CLINICAL SIGNIFICANCE OF THE SPECTRUM OF INTERACTIONS OF THE RARE IVS-II-5 G>C (HBB: C.315+5 G>C) VARIATION WITH OTHER Β-THALASSEMIA MUTATIONS IN SOUTHERN CHINA. Mediterranean Journal of Hematology and Infectious Diseases. 14(1). e2022034–e2022034.
10.
Yang, Xiaorong, Hui Chen, Jinyu Man, et al.. (2021). Secular trends in the incidence and survival of all leukemia types in the United States from 1975 to 2017. Journal of Cancer. 12(8). 2326–2335. 9 indexed citations
11.
Yang, Kun, et al.. (2020). THALIDOMIDE FOR PATIENTS WITH THALASSEMIA INTERMEDIA: A RETROSPECTIVE MULTICENTER CLINICAL STUDY. Mediterranean Journal of Hematology and Infectious Diseases. 12(1). e2020021–e2020021. 20 indexed citations
12.
Yang, Kun, Yi Wu, Yanni Ma, et al.. (2020). The association of HBG2, BCL11A, and HBS1L-MYB polymorphisms to thalidomide response in Chinese β-thalassemia patients. Blood Cells Molecules and Diseases. 84. 102442–102442. 7 indexed citations
13.
14.
Zhou, Yali, Li Wang, Yong‐Sheng Chen, et al.. (2018). Clinical trial on the effects of thalidomide on hemoglobin synthesis in patients with moderate thalassemia intermedia. Annals of Hematology. 97(10). 1933–1939. 23 indexed citations
15.
Zhou, Yali, et al.. (2017). Thalidomide has a significant effect in patients with thalassemia intermedia. Hematology. 23(1). 50–54. 19 indexed citations
16.
Shen, Chao, Mingtai Chen, Xinhua Zhang, et al.. (2016). The PU.1-Modulated MicroRNA-22 Is a Regulator of Monocyte/Macrophage Differentiation and Acute Myeloid Leukemia. PLoS Genetics. 12(9). e1006259–e1006259. 52 indexed citations
17.
Chen, Yongsheng, et al.. (2015). Effect of the microtransplantation of allogeneic hematopoietic stem cells as maintenance therapy for elderly patients with acute leukemia. Oncology Letters. 9(5). 2331–2334. 4 indexed citations
18.
Shi, Xinli, Jing Yang, Nan Mao, et al.. (2014). Nutlin-3-induced redistribution of chromatin-bound IFI16 in human hepatocellular carcinoma cells in vitro is associated with p53 activation. Acta Pharmacologica Sinica. 36(2). 252–258. 11 indexed citations
19.
Yin, Xiaolin, et al.. (2011). Treatment and complications of thalassemia major in Guangxi, Southern China. Pediatric Blood & Cancer. 57(7). 1174–1178. 19 indexed citations
20.
Yin, Xiaolin, Ying Liu, Jing Chen, et al.. (2010). Association of Toll-Like Receptor 4 Gene Polymorphism and Expression with Urinary Tract Infection Types in Adults. PLoS ONE. 5(12). e14223–e14223. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Renée M. Ned Breakdown of academic impact, for papers by Jan Mužı́k Breakdown of academic impact, for papers by Masaru Ido Breakdown of academic impact, for papers by Helen C. Owen Breakdown of academic impact, for papers by Ahmad Gharehbaghian Breakdown of academic impact, for papers by Sheng-Fung Lin Breakdown of academic impact, for papers by Tae Sung Park Breakdown of academic impact, for papers by Anna L. Peters Breakdown of academic impact, for papers by D. Maroeska W. M. te Loo Breakdown of academic impact, for papers by Shano Naseem
Rankless by CCL
2026